After 12 months, GLP-1 users shed 14.8% of the weight they had regained versus 8.1% for nonusers. Researchers stress the study was observational and small.
Recap by typeshit. Full story at Regenstrief Institute.
PHL17 shares findings that people on Ozempic and similar drugs are cutting alcohol spending at bars, restaurants and home.
Gaetano Santulli's team surveys approved oral options and late-stage pill candidates, arguing they could reach patients who avoid injections.
Omer Raheem says he presented his team's work on GLP-1 therapies past weight loss at the ISSM Journals Webinar 2026.
Pratt's rat research suggests GLP-1 signaling can blunt reward-driven eating. He says evidence doesn't yet support GLP-1s as a binge eating disorder treatment.
USA TODAY hears from experts who see GLP-1 drugs as only one part of diabetes care and point to continuous glucose monitors as a useful addition.
STAT
The temporary enforcement discretion covers six peptides an FDA advisory committee recommended in July. STAT notes there is little evidence for many of these wellness compounds.
Loading…